Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / VRNA - Verona Pharma: A Few Points From The Bull And Bear Case

VRNA - Verona Pharma: A Few Points From The Bull And Bear Case

Verona Pharma plc

2024-02-15 17:55:08 ET

Summary

  • VRNA's ensifentrine could be approved for the maintenance treatment of chronic obstructive pulmonary disease in June 2024.
  • VRNA had $257M in cash at the end of Q3'23, and a debt facility worth up to $400M was set up in early 2024.
  • While VRNA has the funding to go it alone in the launch of the ensifentrine, a buyout is still a possibility.

...

For further details see:

Verona Pharma: A Few Points From The Bull And Bear Case
Stock Information
Company Name: Verona Pharma plc
Stock Symbol: VRNA
Market: NASDAQ
Website: veronapharma.com
Menu
VRNA VRNA Quote VRNA Short VRNA News VRNA Articles VRNA Message Board
Get VRNA Alerts

News, Short Squeeze, Breakout and More Instantly...